New Jersey Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.

Press releases published on September 17, 2026

Wandercraft Launches Eve™, the World’s First Self-Balancing Personal Exoskeleton, Bringing Hands-Free Upright Mobility to the Home
Precision Optics Announces Initial Engineering Order from New Satellite Optical Communications Customer
Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction
HealthEdge Named to TIME Magazine’s 2026 List of the World’s Top HealthTech Companies
Integrity Urgent Care Clinic Opens in White Oak, Texas
NeOnc Eliminates Major Dilution Risk as Clinical Story Accelerates
BayCare Names Brendan Malik, MD, Vice President of Physician Enterprise Development and Chief Medical Officer
Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors
Sienna Continues Platform Growth in Ontario
MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)
Emanate Receives FDA 510(k) Clearance for Perio PODS™, the First FDA-Cleared At-Home Periodontal Wound Dressing Indicated Following Non-Surgical Periodontal Procedures
PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
TOMI’s SteraMist Integrated System (SIS) Strategy Converts to Orders: Enclosure Sales Reach $2.3 Million YTD
PharmAla Biotech Provides Corporate Update: Change of Auditor, Retention of Watertower Research and Oak Hill
Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome
Commure Named to TIME's World’s Top HealthTech Companies for Second Consecutive Year
Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
Matisse Pharmaceuticals closed Series A financing round to advance isupartob sodium through phase 2 clinical development

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

New Jersey Health Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.